High-Profile Focus: Life Sciences
14
PerkinElmer Opens Center
Tagline: Trade Gothic Lt Std
Mass. Life Sciences Center vice president for marketing and communications, Angus McQuilken, joins PerkinElmer chairman & CEO, Rob Friel, and additional Perkin Elmer members for the ribbon-cutting ceremony. Hopkinton, MA - PerkinElmer, Inc. announced the opening of a new Center for Innovation in Hopkinton. The facility features a state-of-the-art laboratory space where PerkinElmer engineers, scientists, and customers can interact and share insights to benefit the life sciences market. The R&D teams working at the facility will focus on the development of new products and applications in key areas such as biotherapeutics, imaging and pathology, biomarker research, and genomic analysis.
“The Boston area is a hub for academic, biotech, and pharmaceutical research organizations, making this expansion an exciting opportunity for us to work more closely with this community,” said Jim Corbett, senior vice president, diagnostics and life sciences and technology. “At the center, researchers will have greater access to training and demos on how these disruptive technologies can enable the advancement of human health.”
November, 2013
Moderna Expands to New HQ Cambridge, MA - Moderna Therapeutics, a pioneering company developing messenger RNA therapeutics™ announced the expansion of its headquarters to Technology Square in Cambridge. With the addition of the new space, Moderna will have up to 100 full-time employees at two locations by the end of 2013. The new site will be the l-r: State Rep. Tim Toomey; Noubar Afeyan, cocenter of Moderna’s R&D and provide a significant increase in founder and chairman, Moderna; managing partner laboratory space for formulation, and CEO, Flagship Ventures; Stephane Bancel, screening, and both in-vivo and president and founding CEO, Moderna; Angus in-vitro studies. The facility hous- McQuilken, vice president for communications & es administrative and corporate marketing, Massachusetts Life Sciences Center. needs as well as IT specialists and Moderna’s previous Cambridge is equipped with state of the art technology headquarters will continue to serve as an adto enable virtual collaboration and cloud- ditional site for manufacturing and quality. based computing.
Ipsen Relocates to Cambridge Cambridge, MA – Ipsen, a global pharmaceutical company headquartered in Paris, plans to relocate its U.S. R&D operations from Milford to Cambridge, Mass. A leading hub for biotechnology research, this site will be key for innovation in targeted therapies across Ipsen’s specialty areas as well as a center of excellence for peptides. The move also brings Ipsen closer to several key partners based in the Cambridge area, including prominent hospital
centers, medical schools, and biotech companies. The company signed an 11-year lease on 62,600 rentable sf of laboratory and office space within the 282,000sf building located at 650 East Kendall Street. The deal was brokered by Cresa Corporate Real Estate, and the property is owned by BioMed Realty Trust Inc. Ipsen is a past participant in the Massachusetts Life Sciences Center’s Cooperative Research Matching Grant program.
Life. Science. Architecture. LAB is a new firm that combines the knowledge and skill of a large firm with the energy of a startup. We have 20 years of lab design experience behind us, and use technology and strategic partnerships to bring an agile, focused and responsive approach your projects. Learn about our approach at labarchitectgroup.com
www.high-profile.com